🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for IBD

Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1 NCT06917963NA2 sites📍 Gdansk📍 Gdynia Medical University of Gdansk · Tests: Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM), S… Stopping PPI Therapy in Inactive IBD NCT07691138Phase 41 site📍 Nottingham University of Nottingham · Tests: Continue PPI Therapy, Withdraw PPI Therapy Epidemiological Study on Invasive Bacterial Diseases NCT06322290n/a38 sites📍 Adria📍 Ancona📍 Andria Meyer Children's Hospital IRCCS · Tests: assessment of pathogens in blood specimens Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis NCT06453317Phase 21 site📍 Lodz Medical University of Lodz · Tests: Infliximab, Ustekinumab Prevalence and Clinical Implications of HPV Infection in Male IBD Patients NCT05911750n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Anal pap smear and oral swab for cytology and HPV testing Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease NCT06719778NA1 site📍 Bamberg Universität Duisburg-Essen · Tests: Two-stage nutritional therapy concept Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation NCT07501078Phase 21 site📍 Ann Arbor Muhammad N Aslam, MD · Tests: Aquamin, Placebo Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation NCT07034443NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: High Intensity Focused Electromagnetic Stimulation Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD NCT06749613NA2 sites📍 Chaïdári📍 Athens Attikon Hospital · Tests: digestive enzymes Probiotics and Biomarkers in Irritable Bowel Syndrome NCT07584278NA1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: Probiotic Supplementation (Lactobacillus Reuteri), Placebo Supplementation Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962Phase 1, Phase 213 sites📍 Scottsdale📍 Sacramento📍 San Francisco Tr1X, Inc. · Tests: TRX103, Cyclophosphamide A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease NCT06221254NA4 sites📍 Beersheba📍 Haifa📍 Petah Tikva Soroka University Medical Center · Tests: COBMINDEX digital application, Human therapist (Control) Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study NCT06896305NA1 site📍 Milan IRCCS Ospedale San Raffaele · Tests: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy, Anti-TNF Therapy Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease NCT06274554Phase 31 site📍 New York Weill Medical College of Cornell University · Tests: Fluconazole, Placebo, IL-23 Therapy Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease NCT07078994Phase 220 sites📍 Barnaul📍 Ufa📍 Moscow Biocad · Tests: anti-TL1A monoclonal antibody, low dose, anti-TL1A monoclonal antibody, medium dose, anti-TL1A monoclonal antibody, hig… HB-adMSCs for the Treatment of Crohn's Disease NCT07077746Phase 21 site📍 Sugar Land Hope Biosciences Research Foundation · Tests: HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells, 0.9% sodium chloride TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1) NCT05903066n/a18 sites📍 Liège📍 Amiens📍 Bordeaux Groupe d'Etude Therapeutique des Affections Inflammatoires … · Tests: Magnetic Resonance Enterography (MRE) An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen Elemental 028 Extra Case Studies NCT06877923NA1 site📍 Trowbridge Nutricia UK Ltd · Tests: Elemental 028 Extra Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome NCT06737666Phase 11 site📍 Beijing Xiyuan Hospital of China Academy of Chinese Medical Sciences · Tests: Tong-Xie-Yao-Fang Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis NCT06359808n/a1 site📍 Xi'an Xijing Hospital Predictive Value of Hydrogen/Methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS. NCT04974593Phase 31 site📍 Jette Universitair Ziekenhuis Brussel · Tests: low fat diet Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD NCT06997965Phase 48 sites📍 Miami📍 Orlando📍 Chicago Alimentiv Inc. · Tests: Mirikizumab Defining Objective Markers of Compliance for Dietary Therapies in IBS NCT07494968NA1 site📍 Ann Arbor University of Michigan · Tests: Diet A - elimination diet, Diet B - healthy eating diet A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab NCT07532213n/a1 site📍 Bern Janssen-Cilag A.G., Switzerland FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis NCT06286709Phase 25 sites📍 Birmingham📍 London📍 London University of Birmingham · Tests: Faecal Microbiota Transplant, FMT Placebo Thalidomide Therapy for VEOIBD NCT06382519n/a1 site📍 Shanghai Children's Hospital of Fudan University · Tests: Thalidomide IBD Strong Peer2Peer for Self-Management of Psychological Distress NCT05722236NA1 site📍 Halifax Jennifer Jones · Tests: IBD Strong Peer2Peer, Waitlist control Microencapsulated Sodium Propionate in IBD Microbiota Modulation NCT07883044NA1 site📍 Padova University of Padova · Tests: Microencapsulated sodium propiolate, Microencapsulated sodium Butyrate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy